96 related articles for article (PubMed ID: 19744247)
1. The isoprenoid pathway and transcriptional response to its inhibitors in the yeast Saccharomyces cerevisiae.
Kuranda K; François J; Palamarczyk G
FEMS Yeast Res; 2010 Feb; 10(1):14-27. PubMed ID: 19744247
[TBL] [Abstract][Full Text] [Related]
2. The YTA7 gene is involved in the regulation of the isoprenoid pathway in the yeast Saccharomyces cerevisiae.
Kuranda K; Grabinska K; Berges T; Karst F; Leberre V; Sokol S; François J; Palamarczyk G
FEMS Yeast Res; 2009 May; 9(3):381-90. PubMed ID: 19416104
[TBL] [Abstract][Full Text] [Related]
3. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Henneman L; van Cruchten AG; Kulik W; Waterham HR
Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
[TBL] [Abstract][Full Text] [Related]
5. Reconstruction of a bacterial isoprenoid biosynthetic pathway in Saccharomyces cerevisiae.
Maury J; Asadollahi MA; Møller K; Schalk M; Clark A; Formenti LR; Nielsen J
FEBS Lett; 2008 Dec; 582(29):4032-8. PubMed ID: 18996117
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency.
Schneiders MS; Houten SM; Turkenburg M; Wanders RJ; Waterham HR
Arthritis Rheum; 2006 Jul; 54(7):2306-13. PubMed ID: 16802371
[TBL] [Abstract][Full Text] [Related]
8. Dolichol biosynthesis in the yeast Saccharomyces cerevisiae: an insight into the regulatory role of farnesyl diphosphate synthase.
Grabińska K; Palamarczyk G
FEMS Yeast Res; 2002 Aug; 2(3):259-65. PubMed ID: 12702274
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells.
Tong H; Holstein SA; Hohl RJ
Anal Biochem; 2005 Jan; 336(1):51-9. PubMed ID: 15582558
[TBL] [Abstract][Full Text] [Related]
10. In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway.
Haney SL; Varney ML; Chhonker Y; Talmon G; Smith LM; Murry DJ; Holstein SA
Pharmacol Res; 2021 May; 167():105528. PubMed ID: 33667685
[TBL] [Abstract][Full Text] [Related]
11. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
12. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor.
Vukelic S; Stojadinovic O; Pastar I; Vouthounis C; Krzyzanowska A; Das S; Samuels HH; Tomic-Canic M
J Biol Chem; 2010 Jan; 285(3):1980-8. PubMed ID: 19903814
[TBL] [Abstract][Full Text] [Related]
13. The Arabidopsis thaliana FPP synthase isozymes have overlapping and specific functions in isoprenoid biosynthesis, and complete loss of FPP synthase activity causes early developmental arrest.
Closa M; Vranová E; Bortolotti C; Bigler L; Arró M; Ferrer A; Gruissem W
Plant J; 2010 Aug; 63(3):512-25. PubMed ID: 20497375
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Antimalarial Activity of Different Inhibitors of the Plasmodial Isoprenoid Synthesis Pathway.
da Silva MF; Saito AY; Peres VJ; Oliveira AC; Katzin AM
Antimicrob Agents Chemother; 2015 Aug; 59(8):5084-7. PubMed ID: 26055383
[TBL] [Abstract][Full Text] [Related]
15. In vivo action of the HRD ubiquitin ligase complex: mechanisms of endoplasmic reticulum quality control and sterol regulation.
Gardner RG; Shearer AG; Hampton RY
Mol Cell Biol; 2001 Jul; 21(13):4276-91. PubMed ID: 11390656
[TBL] [Abstract][Full Text] [Related]
16. Redirection of flux through the FPP branch-point in Saccharomyces cerevisiae by down-regulating squalene synthase.
Paradise EM; Kirby J; Chan R; Keasling JD
Biotechnol Bioeng; 2008 Jun; 100(2):371-8. PubMed ID: 18175359
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin-induced PC-12 cell differentiation is associated with RhoA/RhoA kinase pathway inactivation.
Fernández-Hernando C; Suárez Y; Lasunción MA
Mol Cell Neurosci; 2005 Aug; 29(4):591-602. PubMed ID: 15951198
[TBL] [Abstract][Full Text] [Related]
18. Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes.
Rondini EA; Duniec-Dmuchowski Z; Cukovic D; Dombkowski AA; Kocarek TA
J Pharmacol Exp Ther; 2016 Aug; 358(2):216-29. PubMed ID: 27225895
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
Ness GC; Zhao Z; Lopez D
Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
[TBL] [Abstract][Full Text] [Related]
20. Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Keller RK; Zhao Z; Chambers C; Ness GC
Arch Biochem Biophys; 1996 Apr; 328(2):324-30. PubMed ID: 8645011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
